Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Sep 01, 2016
Thermal analysis, X-ray powder diffraction and electron microscopy data related with the production of 1:1 Caffeine:Glutaric Acid cocrystals
Read more
Scientific Article
/ Jul 01, 2017
Self-Association of Rafoxanide in Aqueous Media and Its Application in Preparing Amorphous Solid Dispersions
Read more
Scientific Article
/ May 30, 2017
Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance
Read more
Scientific Article